Cannabis use and the prevalence of current asthma among adolescents and adults in the United States.

Cannabis use has increased among adolescents and adults in the United States (US) in recent years. Few data are available on the prevalence of asthma by frequency of cannabis use. This study aimed to estimate the prevalence of asthma by frequency of past 30-day cannabis use among US individuals. Data were drawn from a nationally representative, annual cross-sectional survey of US individuals aged 12 and older in the United States (N = 32,893), the 2020 National Survey on Drug Use and Health (NSDUH). Logistic regression models were used to examine the relationship between frequency of any cannabis and/or blunt (i.e., cannabis smoked in a hollowed-out cigar) use in the past 30 days among individuals with current asthma. A dose-response relationship between the frequency of cannabis use and current asthma prevalence was examined, adjusting for demographics and current cigarette smoking. Current asthma was more common among US individuals who reported cannabis use in the past 30-days, relative to those who did not (9.8% vs. 7.4%, p < 0.0001). The odds of asthma was significantly greater among individuals reporting cannabis use 20-30 days/month (Adjusted Odds Ratio [AOR] = 1.67, 95% CI:1.21, 2.31), blunt use 6-15 and 20-30 days/month (AOR = 1.9, 95% CI:1.1, 3.2; and AOR = 2.2, 95% CI:1.4, 3.6), respectively, than in those without. A positive linear relationship was observed between frequency of cannabis use (p < 0.0001), blunt use (p < 0.0001) and current asthma prevalence. Findings suggest a dose-response relationship between frequency of current cannabis use and the prevalence of current asthma in the US individuals.

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.